Shandong Suncadia Medicine Co., Ltd.
Shandong Suncadia Medicine Co., Ltd.
Explore linked clinical trials.37 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 3 Study of HRS-8080 Versus Treatment Chosen by Physicians in Locally Advanced and Metastatic Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 3 | 2026-10-02 | NCT07024173 | |
| Phase III Study of HRS-7535 for Hypertension With Overweight or Obesity | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Recruiting | Phase 3 | 2026-09-24 | NCT07528027 | |
| Safety and Pharmacokinetics of HRS-1597 Tablets in Healthy and Obese Participants: A Phase 1 Study | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, metabolic disease, nutritional disorder, obesity disorder, overnutrition | Not yet recruiting | Phase 1 | 2026-09-09 | NCT07808918 | |
| Clinical Study of HRS-2129 for Acute Gouty Arthritis | Acute Gouty Arthritis | Recruiting | Phase 2 | 2026-09-03 | NCT07706777 | |
| A Trial of HRS-1780 in Participants With Uncontrolled Hypertension or Resistant Hypertension. | Uncontrolled or Resistant Hypertension | Not yet recruiting | Phase 2 / Phase 3 | 2026-09-01 | NCT07708441 | |
| A Phase II Clinical Study on the Efficacy and Safety of HRS-1780 in Participants With Primary Aldosteronism | adrenal gland disorder, adrenal gland hyperfunction, endocrine system disorder, hyperaldosteronism, primary aldosteronism | Recruiting | Phase 2 | 2026-08-31 | NCT07470983 | |
| A Clinical Study of HRS-7156 in Healthy Participants | cardiovascular disorder, heart disorder, heart failure | Recruiting | Phase 1 | 2026-08-24 | NCT07601087 | |
| A Phase III Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy | aortic valve disorder, aortic valve stenosis, cardiomyopathy, cardiovascular disorder, heart disorder, heart valve disorder, hypertrophic cardiomyopathy, subvalvular aortic stenosis | Active, not recruiting | Phase 3 | 2026-08-24 | NCT07021976 | |
| Study of Oral HRS-5346 in Adult Patients With Elevated Lipoprotein(a) and High Risk of Cardiovascular Events | Lipoprotein Disorder | Not yet recruiting | Phase 2 | 2026-08-17 | NCT07767513 | |
| Phase I Clinical Study Evaluating the Relative Bioavailability of Different Formulations of HRS-5346 in Healthy Participants | Lipoprotein Disorder | Not yet recruiting | Phase 1 | 2026-08-07 | NCT07752069 | |
| A Phase III Clinical Study on the Efficacy and Safety of HRS-1780 in the Treatment of Patients With Chronic Kidney Disease | Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, chronic renal failure syndrome, kidney disorder, kidney failure, urinary system disorder | Recruiting | Phase 3 | 2026-07-17 | NCT07419828 | |
| Human Mass Balance Study of [¹⁴C]HRS-1893 | cardiomyopathy, cardiovascular disorder, heart disorder | Not yet recruiting | Phase 1 | 2026-06-18 | NCT07656779 | |
| An Open-label, Multicenter, Phase II Clinical Study to Evaluate HRS-7058 in Patients With Pancreatic Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Recruiting | Phase 2 | 2026-06-11 | NCT07589569 | |
| Renal Efficacy and Safety of the Novel Oral Small-Molecule GLP-1RA HRS-7535 Evaluated in Participants With Chronic Kidney Disease | Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, chronic renal failure syndrome, kidney disorder, kidney failure, urinary system disorder | Not yet recruiting | Phase 3 | 2026-06-04 | NCT07625774 | |
| A Study to Evluate Efficacy and Safety of HRS-8080 Combined With Dalpiciclib in Patients With Advanced or Metastatic Breast Cancer Resistant to Adjuvant Endocrine Therapy. | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 3 | 2026-06-02 | NCT07354022 | |
| A Phase 2 Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of HRS-7085 Tablets in Patients With Inflammatory Bowel Disease | Adult Patients With Moderately to Severely Active Ulcerative Colitis | Recruiting | Phase 2 | 2026-06-02 | NCT07229950 | |
| A Phase I/II of HRS-6719 in Patients With Advanced/Metastatic Solid Tumors | Advanced/Metastatic Solid Tumors | Recruiting | Phase 1 / Phase 2 | 2026-05-28 | NCT06922357 | |
| A Trial of HRS-7058 in Advanced or Metastatic Non-Small Cell Lung Cancer Patients Who Have Failed Standard Treatment | KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer Patients Who Have Failed Standard Treatment | Not yet recruiting | Phase 3 | 2026-05-22 | NCT07601048 | |
| A Phase III Trial Comparing HRS-8080 With Standard Endocrine Therapy in Patients With Intermediate or High Risk Early Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 3 | 2026-05-22 | NCT07349069 | |
| A Phase II Clinical Trial of HRS-1893 in the Treatment of Heart Failure With Preserved Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Recruiting | Phase 2 | 2026-05-11 | NCT07269717 | |
| A Mass Balance Study of [14C]HRS-1780 in Healthy Adult Male Subjects | Chronic Disease, Chronic Kidney Diseases, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, chronic renal failure syndrome, kidney disorder, kidney failure, urinary system disorder | Not yet recruiting | Phase 1 | 2026-04-29 | NCT07557407 | |
| A Study of HRS-2129 in Patients With Diabetic Peripheral Neuropathic Pain | Diabetic Peripheral Neuropathic Pain | Recruiting | Phase 1 | 2026-04-15 | NCT07377721 | |
| A Study of HRS-6208 in Combination With HRS-8080, or Fulvestrant, or Letrozole, With or Without HRS-6209 in Patients With Advanced Unresectable or Metastatic Breast Cancer | Advanced Unresectable or Metastatic Breast Cancer of Adults | Recruiting | Phase 1 / Phase 2 | 2026-04-03 | NCT07389733 | |
| A Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HRS-3802 Monotherapy in Patients With Malignant Solid Tumors | Advanced Solid Tumors | Recruiting | Phase 1 | 2026-03-30 | NCT06770569 | |
| A Clinical Trial of HRS-7058 Combined Anti-tumor Drugs in Subjects With Solid Tumors | Solid Tumors | Recruiting | Phase 2 | 2026-03-20 | NCT07032077 |